 Emily Gurnee
Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urticaria Pigmentosa | 2 | 2020 | 2 | 1.340 |
Why?
| | Mastocytosis, Cutaneous | 2 | 2020 | 5 | 1.330 |
Why?
| | Mastocytosis | 2 | 2020 | 12 | 1.310 |
Why?
| | Dermatology | 4 | 2022 | 126 | 1.250 |
Why?
| | Acne Vulgaris | 2 | 2022 | 28 | 0.810 |
Why?
| | Hemolysin Proteins | 1 | 2020 | 34 | 0.690 |
Why?
| | Staphylococcus | 1 | 2020 | 76 | 0.680 |
Why?
| | Bacterial Toxins | 1 | 2020 | 105 | 0.670 |
Why?
| | Mastocytosis, Systemic | 1 | 2019 | 8 | 0.630 |
Why?
| | Skin | 2 | 2020 | 751 | 0.610 |
Why?
| | Dermoscopy | 1 | 2018 | 10 | 0.590 |
Why?
| | Complementary Therapies | 1 | 2019 | 88 | 0.580 |
Why?
| | Anaphylaxis | 1 | 2019 | 105 | 0.560 |
Why?
| | Ecchymosis | 1 | 2017 | 4 | 0.540 |
Why?
| | Plant Extracts | 1 | 2019 | 202 | 0.540 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 329 | 0.540 |
Why?
| | Health Resources | 1 | 2018 | 119 | 0.530 |
Why?
| | Ciprofloxacin | 1 | 2015 | 29 | 0.470 |
Why?
| | Intimate Partner Violence | 1 | 2017 | 89 | 0.460 |
Why?
| | Dietary Supplements | 1 | 2019 | 559 | 0.460 |
Why?
| | Patient Preference | 1 | 2017 | 190 | 0.450 |
Why?
| | Carrier State | 1 | 2015 | 67 | 0.450 |
Why?
| | Escherichia coli Infections | 1 | 2015 | 111 | 0.450 |
Why?
| | Bacterial Proteins | 1 | 2020 | 872 | 0.450 |
Why?
| | Feces | 2 | 2015 | 481 | 0.430 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 185 | 0.430 |
Why?
| | Enterococcus | 1 | 2013 | 23 | 0.430 |
Why?
| | Gastrointestinal Tract | 1 | 2015 | 195 | 0.390 |
Why?
| | Escherichia coli | 1 | 2015 | 807 | 0.350 |
Why?
| | Clinical Competence | 1 | 2018 | 1090 | 0.340 |
Why?
| | Tryptases | 2 | 2020 | 13 | 0.330 |
Why?
| | Pediatrics | 1 | 2018 | 1094 | 0.330 |
Why?
| | Skin Diseases | 2 | 2024 | 149 | 0.320 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 449 | 0.310 |
Why?
| | Down Syndrome | 2 | 2024 | 489 | 0.280 |
Why?
| | Child | 9 | 2024 | 21816 | 0.260 |
Why?
| | Child, Preschool | 7 | 2024 | 10997 | 0.230 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1796 | 0.230 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 26 | 0.230 |
Why?
| | Piperidines | 1 | 2024 | 206 | 0.200 |
Why?
| | Pyrimidines | 1 | 2024 | 470 | 0.180 |
Why?
| | Telemedicine | 2 | 2022 | 852 | 0.180 |
Why?
| | Balsams | 1 | 2020 | 2 | 0.170 |
Why?
| | Genital Diseases, Female | 1 | 2020 | 28 | 0.170 |
Why?
| | Infant | 5 | 2024 | 9395 | 0.170 |
Why?
| | Adolescent | 5 | 2024 | 21380 | 0.160 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2020 | 73 | 0.160 |
Why?
| | Skin Diseases, Vesiculobullous | 1 | 2019 | 18 | 0.160 |
Why?
| | Hemolysis | 1 | 2020 | 206 | 0.150 |
Why?
| | Infant, Newborn | 3 | 2024 | 6031 | 0.150 |
Why?
| | Exanthema | 1 | 2019 | 78 | 0.150 |
Why?
| | Humans | 14 | 2024 | 136750 | 0.150 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 91 | 0.150 |
Why?
| | Mast Cells | 1 | 2019 | 147 | 0.140 |
Why?
| | Teaching Rounds | 1 | 2018 | 67 | 0.130 |
Why?
| | Mandatory Reporting | 1 | 2017 | 45 | 0.130 |
Why?
| | Child Protective Services | 1 | 2017 | 48 | 0.130 |
Why?
| | Adult | 6 | 2024 | 37626 | 0.120 |
Why?
| | Female | 8 | 2024 | 72785 | 0.120 |
Why?
| | Molecular Typing | 1 | 2015 | 22 | 0.120 |
Why?
| | Education, Medical | 1 | 2018 | 259 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2015 | 199 | 0.110 |
Why?
| | Poverty | 1 | 2018 | 520 | 0.110 |
Why?
| | Vancomycin Resistance | 1 | 2013 | 16 | 0.110 |
Why?
| | Methicillin Resistance | 1 | 2013 | 18 | 0.110 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 477 | 0.110 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2819 | 0.100 |
Why?
| | Male | 6 | 2024 | 67305 | 0.090 |
Why?
| | Young Adult | 3 | 2024 | 13126 | 0.090 |
Why?
| | Genotype | 1 | 2015 | 1914 | 0.080 |
Why?
| | Prevalence | 1 | 2015 | 2708 | 0.070 |
Why?
| | Internship and Residency | 1 | 2018 | 1127 | 0.070 |
Why?
| | United States | 3 | 2024 | 14682 | 0.070 |
Why?
| | Prospective Studies | 2 | 2022 | 7572 | 0.070 |
Why?
| | Mothers | 1 | 2013 | 752 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2024 | 15499 | 0.070 |
Why?
| | International Classification of Diseases | 1 | 2024 | 132 | 0.050 |
Why?
| | Pyrroles | 1 | 2024 | 213 | 0.050 |
Why?
| | Canada | 1 | 2024 | 421 | 0.050 |
Why?
| | Pregnancy | 1 | 2015 | 6727 | 0.050 |
Why?
| | Isotretinoin | 1 | 2022 | 26 | 0.050 |
Why?
| | Genitalia, Female | 1 | 2020 | 38 | 0.040 |
Why?
| | Administration, Topical | 1 | 2020 | 149 | 0.040 |
Why?
| | Drug Eruptions | 1 | 2019 | 27 | 0.040 |
Why?
| | Autoimmunity | 1 | 2024 | 908 | 0.040 |
Why?
| | Afghanistan | 1 | 2018 | 71 | 0.040 |
Why?
| | Fever | 1 | 2019 | 306 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2022 | 656 | 0.030 |
Why?
| | Culturally Competent Care | 1 | 2018 | 61 | 0.030 |
Why?
| | Internationality | 1 | 2018 | 154 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1496 | 0.030 |
Why?
| | Cytokines | 1 | 2024 | 2084 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1480 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1282 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1693 | 0.020 |
Why?
| | Curriculum | 1 | 2018 | 973 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1162 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 5739 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 33225 | 0.010 |
Why?
|
|
Gurnee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|